← All organizations
Highest phase reached
Phase 3
First clinical trial
Sep 30, 2018Last known activity
Aug 22, 2023
Timeline
2010s
- Jun 1, 2016
Respirent Pharmaceuticals Co Ltd.— Founded
Drugs by trial phase (3 distinct, 16 trials)
Phase 3 (2 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (16)
- NCT06025214Lead sponsorPhase 1Aug 22, 2023
- NCT05982990Lead sponsorPhase 1Aug 1, 2023
- NCT05697003Lead sponsorPhase 1Feb 17, 2023
- NCT05664061Lead sponsorPhase 3Dec 20, 2022
- NCT05397834Lead sponsorPhase 1May 11, 2022
- NCT05021887Lead sponsorPhase 1Aug 13, 2021
- NCT04665895Lead sponsorPhase 3Dec 10, 2020
- NCT04564456Lead sponsorPhase 1Sep 22, 2020
- NCT04546256Lead sponsorPhase 1Sep 1, 2020
- NCT04462822Lead sponsorPhase 1Aug 24, 2020
- NCT04124094Lead sponsorPhase 1Oct 1, 2019
- NCT03975166Lead sponsorPhase 1May 21, 2019
- NCT03894280Lead sponsorPhase 1Mar 12, 2019
- NCT03820180Lead sponsorPhase 1Jan 23, 2019
- NCT03751202Lead sponsorPhase 1Nov 20, 2018
Details
- Founded
- Chongqing, CN Jun 1, 2016
- Last known activity
- Aug 22, 2023